- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02999321
The Effects of Aspartame on Appetite, Body Composition and Oral Glucose Tolerance
January 16, 2018 updated by: Richard Mattes, Purdue University
Assess the impact of chronic use of aspartame on glycemia, appetite and body composition.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Participants will be randomly assigned to one of three parallel arms: 0% (water), 5 mg, 15mg aspartame.
Participants will have an oral glucose tolerance test at the beginning and end of a 12 week intervention. .
Participants will report to the lab weekly for 12 weeks to pick up their next week's intervention products and measurements for body weight, waist circumference, blood pressure and heart rate.
They will consume their intervention products daily for 12 weeks.
They will record appetite sensations and collect a 24 hour urine sample at weeks 0, 4, 8, and 12.
Study Type
Interventional
Enrollment (Actual)
93
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
West Lafayette, Indiana, United States, 47907
- Purdue Univeristy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI 18-25
- Fasting blood sugar between 72 and 108 mg/dl via capillary finger-stick.
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 0% aspartame (water)
participants will not have any aspartame, this is a control.
|
control group
|
|
Experimental: 5 mg aspartame
participants will receive 5 mg aspartame in a beverage.
|
will be given 5mg aspartame or 15 mg aspartame
|
|
Experimental: 15mg aspartame
participants will receive 5 mg aspartame in a beverage, and 10mg in capsules.
|
will be given 5mg aspartame or 15 mg aspartame
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change oral glucose tolerance
Time Frame: week 0 4 hours
|
sample taken at time point 0
|
week 0 4 hours
|
|
change oral glucose tolerance
Time Frame: week 0 4 hours
|
sample taken at time point 15 minutes post glucola
|
week 0 4 hours
|
|
change oral glucose tolerance
Time Frame: week 0 4 hours
|
sample taken at time point 30 minutes post glucola
|
week 0 4 hours
|
|
change oral glucose tolerance
Time Frame: week 0 4 hours
|
sample taken at time point 60 minutes post glucola
|
week 0 4 hours
|
|
change oral glucose tolerance
Time Frame: week 0 4 hours
|
sample taken at time point 90 minutes post glucola
|
week 0 4 hours
|
|
change oral glucose tolerance
Time Frame: week 0 4 hours
|
sample taken at time point 120 minutes post glucola
|
week 0 4 hours
|
|
change oral glucose tolerance
Time Frame: week 0 4 hours
|
sample taken at time point 180 minutes post glucola
|
week 0 4 hours
|
|
change oral glucose tolerance
Time Frame: week 0 4 hours
|
sample taken at time point 240 minutes post glucola
|
week 0 4 hours
|
|
change oral glucose tolerance
Time Frame: week 12 4 hours
|
sample taken at time point 0
|
week 12 4 hours
|
|
change oral glucose tolerance
Time Frame: week 12 4 hours
|
sample taken at time point 15 minutes post glucola
|
week 12 4 hours
|
|
change oral glucose tolerance
Time Frame: week 12 4 hours
|
sample taken at time point 30 minutes post glucola
|
week 12 4 hours
|
|
change oral glucose tolerance
Time Frame: week 12 4 hours
|
sample taken at time point 60 minutes post glucola
|
week 12 4 hours
|
|
change oral glucose tolerance
Time Frame: week 12 4 hours
|
sample taken at time point 90 minutes post glucola
|
week 12 4 hours
|
|
change oral glucose tolerance
Time Frame: week 12 4 hours
|
sample taken at time point 120 minutes post glucola
|
week 12 4 hours
|
|
change oral glucose tolerance
Time Frame: week 12 4 hours
|
sample taken at time point 180 minutes post glucola
|
week 12 4 hours
|
|
change oral glucose tolerance
Time Frame: week 12 4 hours
|
sample taken at time point 240 minutes post glucola
|
week 12 4 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Appetite
Time Frame: every hour for 1 day at week 0
|
questionnaire on hunger, fullness, desire to eat, prospective consumption, thirst taken hourly for one day.
|
every hour for 1 day at week 0
|
|
Appetite
Time Frame: every hour for 1 day at week 4
|
questionnaire on hunger, fullness, desire to eat, prospective consumption, thirst taken hourly for one day
|
every hour for 1 day at week 4
|
|
Appetite
Time Frame: every hour for 1 day at week 8
|
questionnaire on hunger, fullness, desire to eat, prospective consumption, thirst taken hourly for one day
|
every hour for 1 day at week 8
|
|
Appetite
Time Frame: every hour for 1 day at week 12
|
questionnaire on hunger, fullness, desire to eat, prospective consumption, thirst taken hourly for one day
|
every hour for 1 day at week 12
|
|
Body composition
Time Frame: week 0
|
body composition measurement Plysmography (BOD POD)
|
week 0
|
|
Body composition
Time Frame: week 12
|
body composition measurement Plysmography (BOD POD)
|
week 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 17, 2016
Primary Completion (Actual)
May 5, 2017
Study Completion (Actual)
May 5, 2017
Study Registration Dates
First Submitted
December 19, 2016
First Submitted That Met QC Criteria
December 20, 2016
First Posted (Estimate)
December 21, 2016
Study Record Updates
Last Update Posted (Actual)
January 18, 2018
Last Update Submitted That Met QC Criteria
January 16, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- 055-045
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Glucose Tolerance
-
University of Missouri-ColumbiaMassachusetts Institute of TechnologyCompletedOral Glucose Tolerance Test
-
University of CopenhagenCompleted
-
Göteborg UniversityÖrebro University, SwedenCompletedBlood Glucose | Lipid Metabolism | Oral Glucose Tolerance Test | Carbohydrate MetabolismSweden
-
University of British ColumbiaCompletedFocus of Study: Oral Tolerance Test With Glucose, Lactose, SucroseCanada
-
University of Texas at AustinDairy Research InstituteCompletedOral Glucose Tolerance Test | High Fat Tolerance TestUnited States
-
Hospital Universitario Dr. Jose E. GonzalezCompletedLow Birth Weight | Oral Glucose Tolerance TestMexico
-
Virginia Polytechnic Institute and State UniversityNational Institute on Aging (NIA)CompletedInsulin Sensitivity | Inflammatory Markers | Continuous Glucose Monitoring | Oral Glucose ToleranceUnited States
-
University of OuluCompletedGlucose ToleranceFinland
-
San Diego State UniversityRecruiting
-
Lund UniversityVinnova; Öste Venture ABCompleted
Clinical Trials on water
-
Polyclinic of the Hospitaller Brothers of St. John...Enrolling by invitationLow Back Pain | Performance Measures | Fatigue RecoveryHungary
-
University Hospital, MontpellierCompletedHealthy | Heat ExposureFrance
-
Essentia Water, LLCHealth Onvector Inc.Completed
-
University of ManitobaCompleted
-
Pharos University in AlexandriaActive, not recruiting
-
Imam Abdulrahman Bin Faisal UniversityThe Saline Water Conversion Corporation Research Institute at Al-Jubail,...CompletedDiabetes Mellitus | Glucose, High Blood | PatientsSaudi Arabia
-
University of Kansas Medical CenterRecruitingPancreatitis | ERCP SurgeryUnited States
-
Montreal Heart InstituteRecruiting
-
Istituto Ortopedico GaleazziRecruiting
-
Kaohsiung Medical University Chung-Ho Memorial...Active, not recruitingQuality of Life | Pain | Head and Neck Cancer | Oral MucositisTaiwan